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According to the basic role of drug side effects in selection of an 
appropriate drug, patient compliance and the quality of life in epileptic 
patients, and forasmuch as new dugs with unknown side effect have 
been introduced, necessity of this research is explained. This study 
was conducted to evaluate the incidence and clinical characteristics of 
anti epileptic drug (AED) related adverse reactions in children.
Material & Methods
In this descriptive study, children less than 14 years old with AED 
side effects referred to the Children’s Medical Center and Mofid 
Childeren’s Hospital (Tehran, Iran) were evaluated during 2010-2012. 
The informations were: sex, age, incriminating drug, type of drug side 
effect, incubation period, history of drug usage, and patient and family 
allergy history. Exclusive criterions were age more than 14 years old 
and reactions due to reasons other than AEDs.
Results
A total of 70 patients with AED reaction were enrolled in this study. 
They included 26 (37%) females and 44 (63%) males. The maximum 
rate of incidence was seen at age less than 5 years old. All the patients 
had cutaneous eruptions that the most common cutaneous drug eruption 
was maculopapular rash. The most common culprit was phenobarbital 
(70%) and the least common was lamotrigine (1.4%).
Conclusion
In this study, we found higher rates of drug rash in patients treated with 
aromatic AEDs and lower rates with non-aromatic AEDs. Various 
endogenous and environmental factors may influence the propensity 
to develop these reactions.
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Epilepsy is a widespread chronic neurological disorder that is characterized by 
recurrent seizures resulting from abnormal excessive or synchronous neuronal 
activity in the brain and by neurobiological, cognitive, psychological, and behavioral 
consequences (1). According to WHO reports, there are 50 million epileptic patients 
in the world that 80% of them live in developing countries (2). 
Two studies reported a prevalence of 1.2-1.8 for epilepsy in Iran (3,4). Drugs are 
the major treatment for seizure, so proper selection and use of antiepileptic drugs 
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hospitalized in Children’s Medical Center and Mofid 
Childeren’s Hospital (Tehran, Iran) were evaluated 
during 2010-2012. All patients were visited by an 
Immunologist and a Pediatric Neurologist to determine 
the seizure and drug-induced side effects. An AED 
adverse reaction was defined as reaction that had no 
other obvious causes apart from an AED, which had 
caused hospitalization. 
The WHO description was used for the classification 
of AEDs’ side effects. Required data and information 
(including identifying data and probable correlated 
risk factors) were collected by clinical evaluation and 
referring to the archive of hospital. These informations 
were as follows: sex, age, incriminating drug, type of 
drug side effect, incubation period, history of drug 
usage,, and allergy history of patients and their family. 
Exclusive criteria was age more than 14 years old 
and adverse reactions to substances other than AEDs 
(food, bite, non-AEDs, etc.). We compared the rate of 
side effects to 11 most commonly used AEDs at our 
center. The drugs included carbamazepine, valproic 
acid (VPA), phenytoin, phenobarbital, clonazepam 
(CZP), oxcarbazepine, lamotrigine, gabapentin (GBP), 
topiramate (TPM), levetiracetam (LEV), and vigabatrin. 
The demographic and baseline patient data and the 
characteristics of drug reactions were summarized using 
descriptive statistics. Groups were compared using 
Pearson’s chi-square test, Fisher’s exact test, and t-test 
for the categorical data. Data Analysis was carried out 
by SPSS 17.0. 
Results
Seventy children hospitalized due to AEDs-related 
cutaneous reactions were included in our study, 44 
(62.9%) of the participants were males and 26 (37.1%) 
were females. Thirty-two (72.7%) out of 44 male cases, 
were less than 5 years old and 12 (27.3%) patients were 
more than 5 years old, whereas in 26 female cases, 16 
patients (61.5%) were less than 5 years old and 10 ( 
38.5%) were more than 5 years of age. The risk of AED-
related cutaneous reactions significantly decreased with 
age (p=0.01).
In all patients, cutaneous reactions initiated as 
maculopapular rash. The most common culprit drug 
was phenobarbital (70%) and the least common was 
(AEDs) can control 60-90% of epileptic patients. Using 
an appropriate drug to control seizure is related to several 
factors, such as:
Accurate diagnosis of seizure type, 
Patient compliance, 
Drug side effects that play an important role in patient 
compliance.
These side effects varies from mild phenomena, such as 
drowsiness and mild gastrointestinal and skin symptoms 
to life threatening side effects, including organs 
failure and severe skin involvement. For instance, the 
mortality rate of Stevens-Johnson syndrome,which is 
a life threatening side effect of AEDs, can be 5-10%. 
Phenytoin, a common drug in seizure treatment, is the 
most cause of hyper-sensitivity syndrome and 10% 
of patients treated with phenytoin had drug eruption. 
Phenobarbital, another common drug, causes various 
skin reactions that are usually self-limited after drug 
discontinuation. Even in the case of newer drugs, such 
as lamotrigine, there are reports of life threatening side 
effects ranging from 1:100 in children to 1:1000 in 
adults. Approximately, 10% of patients used lamotrigine 
experienced drug eruption.
Hyper-sensitivity syndrome, which is defined by fever, 
rash, lymphadenopathy, and derangement of liver 
function test can be seen in 1/100 to 1/1000 patients 
treated with AEDs (5).
In different studies the prevalence of AEDs side effect 
varied from 10 to more than 70% (6). 
As drug side effects have a basic role in the selection 
of an appropriate drug, patient compliance, and quality 
of life in epileptic patients, and as newer drugs with 
unknown side effects have been introduced for the 
treatment of seizure, necessity of this study and similar 
studies is explained. The objectives of the present 
study were to evaluate the incidence of drug reactions 
following ingestion of AEDs, to study both traditional 
and newer drugs side effects, and to investigate whether 
clinical factors, such as age, gender, past history, family 
history of allergy and using concomitant drugs influence 
AED-related side effects.
Materials & Methods
This study was a descriptive study. Children less than 
14 years old, with AEDs side effects referred and 
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lamotrigin (1.4%,) (Table 1).
Eighteen patients (25.7%) had generalized erythroderma, 
secondary to phenobarbital in 11 patients, phenytoin in 4, 
carbamazepine in 2, and valproic acid in one patient. Four 
patients (5.7%) had macular rash, fever, leukocytosis 
with eosinophylia and disturbances in liver function tests, 
and hospitalized due to Drug Rash with Eosinophilia and 
Systemic Syndrome impression (DRESS) (Figure 1). In 
all of them the drug was Phenobarbital. Two patients 
(2.8%) experienced Stevens-Johnson syndrome with 
cutaneous eruption, at least two mucosal involvement 
and leukocytosis and erythrocyte sedimentation rate 
(ESR) incease. One with phenobarbital and another with 
Lamotrigine (Table 1) (Figure 2). 
In 5 (7.1%) patients, symptoms initiated less than 24h 
after treatment, 65 patients’ symptom initiated after 
24 h, and in 59 (84.2%), symptom initiation was before 
the first week and in 6 (8.5%) was after the first week 
of treatment.





1 (1.4%)4 (5.7%) 11 (15.8%)49 (70 %)49 (70 %)Phenobarbital
001 (1.4%)10 (14.3%)10 (14.3%)Valproic acid
002 (2.8%)6 (8.6%)6 (8.6%)Carbamazepin
004 (5.7%)4 (5.7%)4 (5.7%)Phenytoin
1 (1.4%)001 (1.4%)1 (1.4%)Lamotrigine
2 (2.8%)4 (5.7%)18 (25.7%)70 (100%)70 (100%)Total
Fig 1. erythroderma Fig 2. Stevens - Johnson syndrome
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involvement) may be due to various enzymes function 
in drug metabolization and their metabolites that are 
different in various ages.
In 5 (7.1%,) patients symptoms initiated less than 24h 
after treatment, 65 patients’ symptom initiated after 
24 h, and in 59 (84.2%) symptom initiation was before 
the first week and in 6 (8.5%) was after the first week of 
treatment, in Brandon’s study, the duration was reported 
from 1 day to 3 weeks (9).
The most common culprit was phenobarbital (70%) and 
the least common was lamotrigine (1.4%). Malekafzali 
and najibi reported that phenytoin is the most prevalent 
cause. Since our study was done on children and since 
phenobarbital was used in the first steps of most of 
the children’s seizures, the prevalence of side effect of 
phenobarbital is highest (8).
A comparative study is needed to determine the 
accumulative effect of AEDs. In other studies, the risk 
of side effects increases with the polytherapy (multiple 
AEDs) (8).
Antibiotics were the more prevalent non-AEDs in 
contemporary use with AEDs. In other studies, antibiotics 
and then AEDs are the most common cause of drug side 
effects (10,11).
In conclusion, in the present study, we found higher 
rates of drug reactions in patients treated with aromatic 
AEDs and lower rates with non-aromatic AEDs. Various 
endogenous and environmental factors may influence 
the propensity to develop these reactions. A high degree 
of suspicion, knowledge about risk factors, and close 
physician–patient contact can raise the possibility of early 
diagnosis and treatment. Diagnosis of severe reactions 
must be completely documented and reported to health 
authorities. The very rare occurrence of life threatening 
events rarely limits treatment decision-making. Future 
epidemiological, chemical, and genetic researches might 
provide methods for determining which patients are at 
risk, so unnecessary exposure should be prevented. 
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